Your browser doesn't support javascript.
loading
Intravascular and intraparenchymatous hepatic segmentary sclerosis
Diniz, Guilherme Velloso; Petroianu, Andy.
Afiliação
  • Diniz, Guilherme Velloso; Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Cirurgia. Belo Horizonte. Brasil
  • Petroianu, Andy; Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Cirurgia. Belo Horizonte. Brasil
Acta cir. bras. ; 33(9): 785-791, set. 2018. ilus
Article em En | VETINDEX | ID: vti-735040
Biblioteca responsável: BR68.1
ABSTRACT

Purpose:

To evaluate the morphological effects of injected sclerosing agents into the liver.

Methods:

This study was performed on twenty dogs, distributed into five groups Group 1 (n = 5) - control, Group 2 (n = 5) - injection of 50% glucose solution inside hepatic parenchyma and animals followed during seven days, Group 3 (n = 10) - injection of ethanol inside hepatic parenchyma and animals distribution into two subgroups Subgroup 3A (n = 5) - followed during 24 hours and subgroup 3B (n = 5) - followed during seven days (group 3B), Group 4 (n = 5) - ethanol injection inside left portal vein branch and followed during 24 hours. Livers were macroscopically evaluated, submitted to hepatic arteriography and portography, then histology.

Results:

All animals in Group 4 died within 23 hours due to diffuse hepatic necrosis. The animals of groups 2 and 3 had a satisfactory evolution. Fibrosis formed in the segment reached by the sclerosant solution and interruption of the contrast flow injected into the portal system.

Conclusion:

Intrahepatic parenchymal ethanol injection is well tolerated and causes sclerosis restricted to a specific segment; however, intraportal ethanol injection causes massive hepatic necrosis and can lead to death.(AU)
Assuntos
Palavras-chave